A critical discovery in cancer research is occurring with the use of mini-antibodies to reactivate mutated p53. This essential tumor inhibitor protein is frequently disabled in various forms of cancer, resulting https://livebookmarking.com/story21952007/vhh-fragments-reactivate-tumor-suppressor-p53-new-new-pathway-for-malignant-treatment